TARDBP and amyotrophic lateral sclerosis: Furthermore, N-(benzothiazolyl)-2-phenyl-acetamides have been characterized as inhibitors for CK1δ-mediated phosphorylation of TDP-43 and may offer new therapeutic possibilities for the treatment of amyotrophic lateral sclerosis (ALS) (373).